9DE7 image
Deposition Date 2024-08-28
Release Date 2025-03-12
Last Version Date 2025-03-19
Entry Detail
PDB ID:
9DE7
Keywords:
Title:
Structure of full-length HIV TAR RNA G16A/A17G
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.25 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polyribonucleotide
Molecule:RNA (58-MER)
Mutations:G16A, A17G, U31G, G32A, C59A
Chain IDs:A
Chain Length:58
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
GTP A G modified residue
Primary Citation
Structures of complete HIV-1 TAR RNA portray a dynamic platform poised for protein binding and structural remodeling.
Nat Commun 16 2252 2252 (2025)
PMID: 40050622 DOI: 10.1038/s41467-025-57519-w

Abstact

The HIV-1 TAR RNA plays key roles in viral genome architecture, transcription and replication. Previous structural analyses focused on its upper stem loop, which has served as a paradigm to study RNA structural dynamics. However, an imperfectly paired lower stem immediately abuts and stacks with the upper half, both of which are required for efficient HIV replication. Here, we report crystal structures of the full-length HIV-1 TAR which reveal substantial conformational mobility in its three conserved bulges and in its lower stem, which coordinately maintain the structural fluidity of the entire RNA. We find that TAR RNA is a robust inhibitor of PKR, and primarily uses its lower stem to capture and sequester PKR monomers, preventing their dimerization and activation. The lower stem exhibits transient conformational excursions detected by a ligation assay. Time-resolved fluorescence spectroscopy reveals local and global TAR structural remodeling by HIV-1 nucleocapsid, Tat, and PKR. This study portrays the structure, dynamics, and interactions of a complete TAR RNA, uncovers a convergent RNA-based viral strategy to evade innate immunity, and provides avenues to develop antivirals that target a dynamic, multifunctional viral RNA.

Legend

Protein

Chemical

Disease

Primary Citation of related structures